Cardiovascular disease: risk assessment and reduction, including lipid modification (NG238)Product type:GuidanceProgramme:NICE guidelinePublished: 14 December 2023
Automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcers (HTG677)Product type:GuidanceProgramme:HealthTech guidancePublished: 24 May 2023
Peripheral arterial disease: diagnosis and management (CG147)Product type:GuidanceProgramme:Clinical guidelineLast updated: 11 December 2020Published: 8 August 2012
Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease (TA607)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 17 October 2019
Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease (TA223)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 May 2011
Cardiovascular disease prevention (PH25)Product type:GuidanceProgramme:Public health guidelinePublished: 22 June 2010
Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin (TA159)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 October 2008